Affiliation:
1. Department of Human Genetics, Roche Molecular Systems, Inc., Alameda, California 945011and
2. Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico 871312
Abstract
ABSTRACT
Amplification of human papillomavirus (HPV) DNA by L1 consensus primer systems (e.g., MY09/11 or GP5
+
/6
+
) can detect as few as 10 to 100 molecules of HPV targets from a genital sample. However, genotype determination by dot blot hybridization is laborious and requires at least 27 separate hybridizations for substantive HPV-type discrimination. A reverse blot method was developed which employs a biotin-labeled PCR product hybridized to an array of immobilized oligonucleotide probes. By the reverse blot strip analysis, genotype discrimination of multiple HPV types can be accomplished in a single hybridization and wash cycle. Twenty-seven HPV probe mixes, two control probe concentrations, and a single reference line were immobilized to 75- by 6-mm nylon strips. Each individual probe line contained a mixture of two bovine serum albumin-conjugated oligonucleotide probes specific to a unique HPV genotype. The genotype spectrum discriminated on this strip includes the high-risk, or cancer-associated, HPV genotypes 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 55, 56, 58, 59, 68 (ME180), MM4 (W13B), MM7 (P291), and MM9 (P238A) and the low-risk, or non-cancer-associated, genotypes 6, 11, 40, 42, 53, 54, 57, 66, and MM8 (P155). In addition, two concentrations of β-globin probes allowed for assessment of individual specimen adequacy following amplification. We have evaluated the performance of the strip method relative to that of a previously reported dot blot format (H. M. Bauer et al., p. 132–152,
in
C. S. Herrington and J. O. D. McGee (ed.),
Diagnostic Molecular Pathology: a Practical Approach
, (1992), by testing 328 cervical swab samples collected in Digene specimen transport medium (Digene Diagnostics, Silver Spring, Md.). We show excellent agreement between the two detection formats, with 92% concordance for HPV positivity (kappa = 0.78,
P
< 0.001). Nearly all of the discrepant HPV-positive samples resulted from weak signals and can be attributed to sampling error from specimens with low concentrations (<1 copy/μl) of HPV DNA. The primary advantage of the strip-based detection system is the ability to rapidly genotype HPVs present in genital samples with high sensitivity and specificity, minimizing the likelihood of misclassification.
Publisher
American Society for Microbiology
Reference24 articles.
1. Bauer
H. M.
Greer
C. E.
Manos
M. M.
Determination of genital human papillomavirus infection using consensus PCR
Diagnostic molecular pathology: a practical approach.
Herrington
C. S.
McGee
J. O. D.
1992
132
152
Oxford University Press
Oxford United Kingdom
2. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia;Bosch F. X.;Cancer Epidemiol. Biomarkers Prev.,1993
3. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective;Bosch F. X.;J. Natl. Cancer Inst.,1995
4. A method for typing polymorphism at the HLA-A locus using PCR amplification and immobilized oligonucleotide probes;Bugawan T. L.;Tissue Antigens,1994
5. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance;Cox J. T.;Am. J. Obstet. Gynecol.,1995